fingolimod hydrochloride has been researched along with cyclin d1 in 3 studies
Studies (fingolimod hydrochloride) | Trials (fingolimod hydrochloride) | Recent Studies (post-2010) (fingolimod hydrochloride) | Studies (cyclin d1) | Trials (cyclin d1) | Recent Studies (post-2010) (cyclin d1) |
---|---|---|---|---|---|
2,771 | 157 | 2,062 | 10,885 | 70 | 5,157 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fan, ST; Ho, JW; Lee, TK; Man, K; Ng, IO; Ng, KT; Sun, CK; Wang, XH; Wong, YC; Xu, R | 1 |
Alinari, L; Baiocchi, RA; Byrd, JC; Chen, CS; Dalton, JT; Lapalombella, R; Lin, T; Liu, Q; Mani, R; Muthusamy, N; Yan, F; Zhang, X | 1 |
Gu, Y; He, Z; Liu, H; Lu, M; Wang, C; Wang, H; Yin, J; Zhang, Z; Zheng, G | 1 |
3 other study(ies) available for fingolimod hydrochloride and cyclin d1
Article | Year |
---|---|
FTY720 induces apoptosis of human hepatoma cell lines through PI3-K-mediated Akt dephosphorylation.
Topics: Apoptosis; Carcinoma, Hepatocellular; Cell Cycle Proteins; Cyclin D1; Cyclin-Dependent Kinase Inhibitor p27; Down-Regulation; Enzyme Inhibitors; Fingolimod Hydrochloride; G1 Phase; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Immunosuppressive Agents; Liver Neoplasms; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Phosphatidylinositol 3-Kinases; Phosphorylation; Propylene Glycols; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Sphingosine; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Tumor Suppressor Proteins | 2004 |
FTY720 shows promising in vitro and in vivo preclinical activity by downmodulating Cyclin D1 and phospho-Akt in mantle cell lymphoma.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Line, Tumor; Cyclin D1; Female; Fingolimod Hydrochloride; Humans; Lymphoma, Mantle-Cell; Mice; Mice, SCID; Propylene Glycols; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species; Sphingosine; Xenograft Model Antitumor Assays | 2010 |
Overexpression of PP2A inhibitor SET oncoprotein is associated with tumor progression and poor prognosis in human non-small cell lung cancer.
Topics: Animals; Blotting, Western; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Cyclin D1; Cyclin-Dependent Kinase Inhibitor p27; Disease Progression; DNA-Binding Proteins; Extracellular Signal-Regulated MAP Kinases; Fingolimod Hydrochloride; Histone Chaperones; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Lymphatic Metastasis; Matrix Metalloproteinase 9; Mice; Neoplasm Staging; Prognosis; Protein Phosphatase 2; Proto-Oncogene Proteins c-akt; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; Transcription Factors; Transplantation, Heterologous | 2015 |